Press Releases

Seattle, WA - Jun 4, 2025

The Sound Life Project – New Finding Identifies Four Categories of Healthy Immune Systems

Categories that may give insight into who and why some people develop immune related diseases

In an article published today in the journal Science Translational Medicine, Benaroya Research Institute (BRI) scientists, led by Megan Smithmyer, PhD, Alex Hu, PhD, Jane Buckner, MD, and Cate Speake, PhD, investigated the range of variability that exists among the immune systems of healthy people. By understanding how the immune system functions in health, scientists will ultimately be laying the groundwork to identify better ways to diagnose, treat, and prevent immune system diseases such as rheumatoid arthritis, type 1 diabetes, and multiple sclerosis. As part of this study, BRI scientists and collaborators from the Allen Institute investigated the immune system in 100 healthy individuals who participated in the Sound Life Project. In addition, they learned that some young, healthy individuals have unusually strong inflammatory responses similar to older adults.

The Sound Life Project is a unique longitudinal study investigating how healthy immune systems differ from each other. Understanding the diversity of healthy immune systems is important because healthy people respond differently to immune diseases and vaccines. Knowing about the wide variety of healthy immune systems will help scientists understand what goes awry during autoimmune diseases. The study was launched in 2019 and followed 100 healthy individuals for 2 years. Participants donated blood samples over 10 visits and self-reported information about diet, exercise, travel, and health through weekly surveys.

Dr. Smithmyer discusses the research team's new publication in Science Translational Medicine

In this first publication from the Sound Life Project, the investigators measured 174 different types of immune cells that circulate in the blood. They determined that 81 of these immune cell types did not change over time within an individual. When they compared the frequencies of the 81 immune cell types across the group of 100 healthy participants, they found that these individuals could be divided into 4 distinct groups, called immunotypes, based on the cell populations in their immune systems. To better understand the features that defined the 4 immunotypes, the Sound Life Project investigators also analyzed which genes were expressed and which proteins were produced in the immune cells of the participants.

“This tour-de-force study is among the first to deeply examine immune variation over time, advancing our understanding of the immune system and age in the context of health. We are very excited to see this type of work continue and grow!” said Dr. Claire Gustafson, an Assistant Investigator in Experimental Immunology at the Allen Institute.

One of the immunotypes was of particular interest as it was defined by increased inflammation as well as a heightened immune response to certain bacterial components. Together, these findings suggest that individuals with this immunotype may be poised to develop autoimmune or inflammatory diseases. “We plan to continue to monitor all the folks in this study to see how the immune system changes with time. We’re especially interested in individuals with this immunotype to determine if they have an increased propensity for developing autoimmune diseases or other immune health concerns. This finding reinforces the need for continued research into the distinct factors that may contribute to autoimmune disease development,” said Dr. Speake.

The results from the Sound Life Project highlight the importance of understanding the healthy immune system in order to predict, prevent, and cure diseases. “BRI will continue to investigate this rich dataset. There is a lot more data to explore and interesting questions to ask about the healthy immune system that the Sound Life Project can help answer,” commented Dr. Buckner.  “We are excited for what’s to come as we further outline what defines a healthy immune system.”

Featured BRI Building Exterior 2024

About Benaroya Research Institute

Benaroya Research Institute (BRI) is a world leader in human immune system research, working to advance the science that will predict, prevent, reverse and cure immune system diseases like allergies, asthma, cancer and autoimmune diseases.

BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies. We believe that a breakthrough in one immune system disease can lead to progress against them all, and work tirelessly toward our vision of a healthy immune system for everyone. BRI is an independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle.

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads, LinkedIn, Bluesky and YouTube.